Prostate cancer Board decisions

The Board has remanded the Veteran's claims for type II diabetes mellitus, prostate cancer, incontinence, and erectile dysfunction due to inadequate examinations that did not consider his reports of service exposure.

The Veteran's residuals of prostate cancer were manifested by voiding dysfunction with daytime voiding interval between two and three hours and awakening to void two times per night from January 1, 2015 to April 17, 2017. A rating in excess of 10 percent was denied.

The Board has remanded the claims of service connection for diabetes mellitus, Type II, prostate cancer, urinary bladder cancer, and erectile dysfunction (ED) as secondary to exposure to Agent Orange due to new evidence added since the March 2020 SOC.

The Veteran's service connection claims for ischemic heart disease, prostate cancer, and erectile dysfunction due to herbicide exposure are granted. The Board found that the Veteran was exposed to herbicides during his service in Thailand and established presumptive service connection for these conditions.

The Veteran's appeal for service connection for depression has been dismissed. Service connection for bilateral hearing loss, tinnitus, and gastroesophageal reflux disease (GERD) have been granted. The remaining issues are being remanded due to lack of a current diagnosis or treatment.

The Veteran's appeal for service connection for prostate cancer with residuals has been dismissed due to his death.

The Board denied the claim for service connection of prostate cancer, finding that there is no causal relationship between the current diagnosis and in-service symptom.

The Board has restored service connection for prostate cancer and erectile dysfunction as secondary to service-connected prostate cancer, finding that the severance of these conditions was improper due to lack of clear and unmistakable error.

The Veteran's attorney withdrew the appeals for prostate cancer and coronary artery disease, leading to their dismissal.

The Veteran's prostate cancer was not service connected as it is presumed to be due to herbicide exposure aboard the USS Mahan. However, there is no evidence that the Veteran served in an area where herbicides were used during his time on the ship.

The Veteran's claims for increased evaluations of his service-connected diabetes mellitus, prostate cancer residuals with voiding dysfunction, and erectile dysfunction are being remanded due to the need for additional examinations and treatment records.

The Board denied the Veteran's claims for service connection for prostate cancer and anemia, finding that his conditions are not related to exposure to contaminated water at Camp Lejeune.

The Board has remanded the case due to insufficient medical evaluation regarding the cause of death and the relationship between the Veteran's conditions. The Appellant is seeking service connection for the cause of her husband's death, which was attributed to carcinomatosis resulting from lung cancer and prostate cancer.

The Board has remanded the claims for service connection for brain tumor and prostate cancer due to conflicting information about the Veteran's exposure to ionizing radiation during his military service. The case will be reviewed with a new dose estimate based on the Veteran's statements regarding his time at the nuclear test site.

The Board denied the restoration of a total disability rating for prostate cancer and granted a 20 percent rating for its residuals. Service connection was established for proctitis secondary to prostate cancer treatment.

The Board has granted service connection for erectile dysfunction as secondary to the Veteran's service-connected prostate cancer residuals, resolving all reasonable doubt in favor of the Veteran.

The Board has determined that there was not substantial compliance with its April 2021 remand orders and another remand of this issue is necessary. The Veteran's treatment records from Walter Reed Hospital are to be obtained, and an addendum opinion as to the nature and etiology of any current prostate disability should be obtained.

The Veteran was granted a TDIU on an extra-schedular basis from January 8, 2016 to April 26, 2016 due to his service-connected disabilities.,The Veteran was also granted a schedular TDIU from April 27, 2016 to February 15, 2022.

The Veteran's prostate cancer is being remanded for a new VA examination to assess the current severity of his disability and provide a retroactive opinion regarding the condition prior to January 31, 2018. The examiner must consider the Veteran's statement about changing absorbent materials.

The Board has remanded the Veteran's claims of service connection for bilateral hearing loss and prostate cancer due to a lack of an examination addressing the nature and etiology of these conditions. The Veteran is not considered a 'radiation-exposed veteran' under 38 C.F.R. § 3.309(d)(3).